Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Non-Hodgkin lymphoma risk in adults living with HIV across five continents

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. No evidence of increased risk of thyroid dysfunction in well-treated people living with HIV

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. No Neurocognitive Advantage for Immediate Antiretroviral Treatment in adults with greater than 500 CD4+ T Cell Counts

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Gregory J Dore
  • Vicente Soriano
  • Jürgen Rockstroh
  • Bernd Kupfer
  • Ellen Tedaldi
  • Lars Peters
  • Jacqueline Neuhaus
  • Massimo Puoti
  • Marina B Klein
  • Amanda Mocroft
  • Bonaventura Clotet
  • Jens D Lundgren
  • SMART INSIGHT study group
Vis graf over relationer
The impact of antiretroviral therapy (ART) interruption in HIV-hepatitis B virus (HBV)-coinfected patients was examined in the Strategic Management of AntiRetroviral Therapy (SMART) study.
OriginalsprogEngelsk
TidsskriftAIDS
Vol/bind24
Udgave nummer6
Sider (fra-til)857-65
Antal sider9
ISSN0269-9370
DOI
StatusUdgivet - 2010

ID: 34777049